Amino acid infusion study aims to unlock fatty liver secrets

NCT ID NCT06240039

Ongoing Knowledge-focused Sponsor: University of Copenhagen Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at how amino acids trigger the liver to release hormones in healthy people and those with non-alcoholic fatty liver disease. Researchers will give amino acid infusions with or without a drug that blocks natural hormone production. By comparing the results, they hope to understand why liver hormone levels are often high in fatty liver disease. The study involves 30 participants and uses MRI scans to measure liver fat.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: amino acid infusion
What this could lead to: If successful, this study could reveal why liver hormone levels are high in fatty liver disease, pointing toward new treatment targets.
What could go wrong: This is a small, early-stage study (30 participants) that only measures short-term effects. It may not translate into treatments or apply to broader populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NON-ALCOHOLIC FATTY LIVER DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

metabolic dysfunction-associated steatotic liver disease Obesity obesity disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

NON-ALCOHOLIC FATTY LIVER DISEASE OBESITY

Contacts and locations

Locations

Bispebjerg University Hospital

Copenhagen, Denmark

More trials for these conditions

Other studies related to the condition(s) this trial covers.